NYSE:RAD

Rite Aid (RAD) Stock Forecast, Price & News

$1.82

-0.01 (-0.54%)

(As of 06/5/2023 ET)

Compare

Today's Range: $1.80
▼
$1.90
50-Day Range: $1.76
▼
$2.63
52-Week Range: $1.67
▼
$11.61

Volume: 1.13 million shs
Average Volume: 1.63 million shs
Market Capitalization: $102.98 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.75

Rite Aid MarketRank™ Forecast

Analyst Rating: Reduce
1.00 Rating Score
Upside/Downside: 50.7% Upside
$2.75 Price Target
Short Interest: Bearish
27.47% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.85
Upright™ Environmental Score
News Sentiment: 0.68
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($4.81) to ($4.39) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.45 out of 5 stars

Retail/Wholesale Sector

191st out of 204 stocks

Drug Stores & Proprietary Stores Industry

5th out of 6 stocks

2.5

Analyst's Opinion

Consensus Rating
Rite Aid has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $2.75, Rite Aid has a forecasted upside of 50.7% from its current price of $1.83.
Amount of Analyst Coverage
Rite Aid has received no research coverage in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
27.47% of the float of Rite Aid has been sold short.
Short Interest Ratio / Days to Cover
Rite Aid has a short interest ratio ("days to cover") of 6.1.
Change versus previous month
Short interest in Rite Aid has recently increased by 0.61%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Rite Aid does not currently pay a dividend.
Dividend Growth
Rite Aid does not have a long track record of dividend growth.

1.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Rite Aid has received a -7.34% net impact score from Upright. On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in categories "Scarce human capital", "GHG emissions", and "Waste". The negative contribution in the "GHG emissions" impact category seems to be driven mostly by its "Physical retail of toilet paper, wipes and diapers at a pharmacy", "Physical retail of beverages at a pharmacy", and "Physical retail of pharmaceuticals at a pharmacy" products. See details.
Environmental Sustainability
The Environmental Impact score for Rite Aid is -1.85.

2.0

News and Social Media Coverage

News Sentiment
Rite Aid has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Retail/Wholesale companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Rite Aid this week, compared to 5 articles on an average week.
Search Interest
Only 11 people have searched for RAD on MarketBeat in the last 30 days. This is a decrease of -48% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Rite Aid to their MarketBeat watchlist in the last 30 days. This is a decrease of -87% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Rite Aid insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.26% of the stock of Rite Aid is held by insiders.
Percentage Held by Institutions
51.76% of the stock of Rite Aid is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Rite Aid are expected to grow in the coming year, from ($4.81) to ($4.39) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Rite Aid is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Rite Aid is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About Rite Aid (NYSE:RAD) Stock

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

RAD Stock News Headlines

June 5, 2023 | finance.yahoo.com

Rite Aid Empowers Customers to Be Themselves with Launch of RYSHI™ Beauty and Personal Care Essentials

May 31, 2023 | msn.com

Rite Aid to permanently close Ballard Bartell Drugs location

June 6, 2023 | Legacy Research (Affiliate) (Ad)

“One-Stock Millionaire” IGNORES 99.9% of the Market

During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.

May 24, 2023 | msn.com

Masterpiece in Dauphin County built by Rite Aid founder for $1.9M: Cool Spaces

May 23, 2023 | finance.yahoo.com

Elixir announces the next wave of innovation for pharmacy benefits technology platform

May 19, 2023 | barrons.com

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm

May 18, 2023 | msn.com

Over 1K In Health And Beauty Aids Swiped From Mt. Sinai Rite Aid: PD

May 15, 2023 | marketwatch.com

CLASS ACTION UPDATE for RAD, HSAI and BIRD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

June 6, 2023 | Legacy Research (Affiliate) (Ad)

Sell Every Stock, Except ONE (Ticker Revealed)

We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.

May 12, 2023 | marketwatch.com

LAWSUITS FILED AGAINST SIVBQ, RAD and MPW - Jakubowitz Law Pursues Shareholders Claims

May 12, 2023 | msn.com

Harrisburg home built by Rite Aid founder listed for sale

May 10, 2023 | americanbankingnews.com

Q1 2024 EPS Estimates for Rite Aid Co. Decreased by Analyst (NYSE:RAD)

May 9, 2023 | marketwatch.com

When Rite Aid ($RAD) Moves Investors should Listen

May 8, 2023 | msn.com

Mayor Evans explains healthy food initiative after Rite Aid closure

May 5, 2023 | marketwatch.com

CLASS ACTION UPDATE for RAD, MARA and FULC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

May 4, 2023 | msn.com

Rite Aid to close Portland Avenue store

May 4, 2023 | news.yahoo.com

Rite Aid set to close three locations in Western New York

April 30, 2023 | americanbankingnews.com

Deutsche Bank Aktiengesellschaft Cuts Rite Aid (NYSE:RAD) Price Target to $1.00

April 27, 2023 | msn.com

Deutsche Bank Maintains Rite Aid (RAD) Sell Recommendation

April 27, 2023 | finance.yahoo.com

Rite Aid Corporation (NYSE:RAD) Q4 2023 Earnings Call Transcript

April 26, 2023 | finance.yahoo.com

Rite Aid Looks to ‘Ease the Sneeze’ This Allergy Season

April 23, 2023 | americanbankingnews.com

Rite Aid (NYSE:RAD) Issues FY 2024 Earnings Guidance

April 23, 2023 | americanbankingnews.com

Rite Aid (NYSE:RAD) Posts Earnings Results, Misses Estimates By $0.47 EPS

April 22, 2023 | americanbankingnews.com

Rite Aid (NYSE:RAD) Upgraded to Hold at StockNews.com

April 21, 2023 | finance.yahoo.com

Q4 2023 Rite Aid Corp Earnings Call

April 20, 2023 | forbes.com

Rite Aid Losses Hit $241 Million As Stores Close And Covid Test And Vaccine Sales Drop

April 20, 2023 | finance.yahoo.com

Rite Aid Corporation Reports Fiscal 2023 Fourth Quarter and Full Year Results and Provides Fiscal 2024 Outlook

See More Headlines

RAD Price History

30 days | 90 days | 365 days | Advanced Chart

RAD Company Calendar

Last Earnings: 4/20/2023
Today: 6/05/2023
Next Earnings (Estimated): 6/22/2023
Fiscal Year End: 2/29/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Drug stores & proprietary stores
Sub-Industry: Drug Retail
Sector: Retail/Wholesale
Current Symbol: NYSE:RAD
CUSIP: 76775410
CIK: 84129
Web: www.riteaid.com
Phone: (717) 761-2633
Fax: 717-975-5871
Employees: 47,000
Year Founded: 1968

Price Target and Rating

Average Stock Price Forecast: $2.75
High Stock Price Forecast: $4.50
Low Stock Price Forecast: $1.00
Forecasted Upside/Downside: +50.7%
Consensus Rating: Reduce
Rating Score (0-4): 1.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($13.72)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-749,940,000.00
Net Margins: -3.11%
Pretax Margin: -3.14%
Return on Equity: N/A
Return on Assets: -1.76%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.21
Quick Ratio: 0.51

Sales & Book Value

Annual Sales: $24.09 billion
Price / Sales: 0.00
Cash Flow: $1.81 per share
Price / Cash Flow: 1.01
Book Value: ($11.35) per share
Price / Book: -0.16

Miscellaneous

Outstanding Shares: 56,430,000
Free Float: 55,152,000
Market Cap: $102.98 million
Optionable: Optionable
Beta: 1.11

Social Links

Key Executives

Elizabeth Burr
Chief Executive Officer & Director

Matthew C. Schroeder
Chief Financial Officer & Executive Vice President

Justin Mennen
Chief Digital & Technology Officer

Jessica Kazmaier
Chief Human Resources Officer & Executive VP

Andre Persaud
Chief Retail Officer & Executive Vice President

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

RAD Stock - Frequently Asked Questions

Should I buy or sell Rite Aid stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last twelve months. There are currently 2 sell ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" RAD shares.
View RAD analyst ratings or view top-rated stocks.
What is Rite Aid's stock price forecast for 2023?: 2 brokerages have issued 12 month price targets for Rite Aid's stock. Their RAD share price forecasts range from $1.00 to $4.50. On average, they anticipate the company's stock price to reach $2.75 in the next year. This suggests a possible upside of 50.7% from the stock's current price.
View analysts price targets for RAD or view top-rated stocks among Wall Street analysts.
How have RAD shares performed in 2023?: Rite Aid's stock was trading at $3.34 at the start of the year. Since then, RAD stock has decreased by 45.4% and is now trading at $1.8250.
View the best growth stocks for 2023 here.
When is Rite Aid's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, June 22nd 2023.
View our RAD earnings forecast.
How were Rite Aid's earnings last quarter?: Rite Aid Co. (NYSE:RAD) announced its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) EPS for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The business had revenue of $6.09 billion for the quarter, compared to analysts' expectations of $5.70 billion. The business's quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($1.63) EPS.
When did Rite Aid's stock split?: Rite Aid shares reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
What guidance has Rite Aid issued on next quarter's earnings?: Rite Aid updated its FY24 earnings guidance on Thursday, April, 20th. The company provided earnings per share (EPS) guidance of ($4.93)-($4.44) for the period, compared to the consensus estimate of ($1.84). The company issued revenue guidance of $21.7-22.1 billion, compared to the consensus revenue estimate of $20.88 billion.
What is Heyward Donigan's approval rating as Rite Aid's CEO?: 169 employees have rated Rite Aid Chief Executive Officer Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among the company's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rite Aid own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).
What is Rite Aid's stock symbol?: Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
Who are Rite Aid's major shareholders?: Rite Aid's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.94%), Charles Schwab Investment Management Inc. (6.26%), Boothbay Fund Management LLC (0.00%), GMT Capital Corp (2.63%), Geode Capital Management LLC (1.83%) and Renaissance Technologies LLC (1.75%). Insiders that own company stock include Heyward R Donigan and Jocelyn Z Konrad.
View institutional ownership trends.
How do I buy shares of Rite Aid?: Shares of RAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Rite Aid's stock price today?: One share of RAD stock can currently be purchased for approximately $1.83.
How much money does Rite Aid make?: Rite Aid (NYSE:RAD) has a market capitalization of $102.98 million and generates $24.09 billion in revenue each year. The company earns $-749,940,000.00 in net income (profit) each year or ($13.72) on an earnings per share basis.
How many employees does Rite Aid have?: The company employs 47,000 workers across the globe.
Does Rite Aid have any subsidiaries?: The following companies are subsidiares of Rite Aid: 1515 West State Street Boise Idaho LLC, 1740 Associates LLC, 4042 Warrensville Center Road—Warrensville Ohio Inc., 5277 Associates Inc., 5600 Superior Properties Inc., Advance Benefits LLC, Apex Drug Stores Inc., Ascend Health Technology LLC, Bartell Drugs, Broadview and Wallings—Broadview Heights Ohio Inc., Design Rx Holdings LLC, Design Rx LLC, Design Rxclusives LLC, Drug Palace Inc., EDC Drug Stores Inc., Eckerd Corporation, Edgehill Drugs, Elixir Holdings LLC, Elixir Insurance Company, Elixir Pharmacy LLC, Elixir Puerto Rico Inc., Elixir Rx Options LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions of Nevada LLC, Elixir Rx Solutions LLC, Elixir Savings LLC, Envision Pharmaceutical, First Florida Insurers of Tampa LLC, GDF Inc., Genovese Drug Stores Inc., Gettysburg and Hoover-Dayton Ohio LLC, Grand River & Fenkell LLC, Harco, Harco Inc., Health Dialog, Health Dialog Services Corporation, Hunter Lane LLC, ILG – 90 B Avenue Lake Oswego LLC, JCG Holdings USA Inc., JCG PJC USA LLC, K&B Alabama Corporation, K&B Incorporated, K&B Industries, K&B Louisiana Corporation, K&B Mississippi Corporation, K&B Services Incorporated, K&B Tennessee Corporation, K&B Texas Corporation, LMW – 90B Avenue Lake Oswego Inc., Lakehurst and Broadway Corporation, Laker Software LLC, Maxi Drug North Inc., Maxi Drug South L.P., Maxi Drug Inc., Maxi Green Inc., Munson & Andrews LLC, Name Rite LLC, P.J.C. Distribution Inc., P.J.C. Realty Co. Inc., PCS Health Systems, PDS-1 Michigan Inc., PJC Lease Holdings Inc., PJC Manchester Realty LLC, PJC Peterborough Realty LLC, PJC Realty MA Inc., PJC Revere Realty LLC, PJC Special Realty Holdings Inc., PJC of Massachusetts Inc., PJC of Rhode Island Inc., PJC of Vermont Inc., Perry Distributors Inc., Perry Drug Stores Inc., RCMH LLC, RDS Detroit Inc., READ’s Inc., RediClinic, RediClinic Associates Inc., RediClinic US LLC, RediClinic of DC LLC, RediClinic of DE LLC, RediClinic of Dallas Forth-Worth LLC, RediClinic of MD LLC, RediClinic of PA LLC, RediClinic of VA LLC, RediClinic LLC, Richfield Road – Flint Michigan LLC, Rite Aid Drug Palace Inc., Rite Aid Hdqtrs. Corp., Rite Aid Hdqtrs. Funding Inc., Rite Aid Lease Management Company, Rite Aid Online Store Inc., Rite Aid Payroll Management Inc., Rite Aid Realty Corp., Rite Aid Rome Distribution Center Inc., Rite Aid Specialty Pharmacy LLC, Rite Aid Transport Inc., Rite Aid of Connecticut Inc., Rite Aid of Delaware Inc., Rite Aid of Georgia Inc., Rite Aid of Indiana Inc., Rite Aid of Kentucky Inc., Rite Aid of Maine Inc., Rite Aid of Maryland Inc., Rite Aid of Michigan Inc., Rite Aid of New Hampshire Inc., Rite Aid of New Jersey Inc., Rite Aid of New York Inc., Rite Aid of North Carolina Inc., Rite Aid of Ohio Inc., Rite Aid of Pennsylvania LLC, Rite Aid of South Carolina Inc., Rite Aid of Tennessee Inc., Rite Aid of Vermont Inc., Rite Aid of Virginia Inc., Rite Aid of Washington D.C. Inc., Rite Aid of West Virginia Inc., Rite Investments Corp., Rite Investments Corp. LLC, Rx Choice Inc., Rx Initiatives LLC, Rx USA Inc., The Bartell Drug Company, The Jean Coutu Group PJC USA Inc., The Lane Drug Company, Thrift Drug Inc., Thrifty Corporation, Thrifty PayLess Inc., and Tonic Procurement Solutions LLC.
Read More
How can I contact Rite Aid?: Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The official website for the company is www.riteaid.com. The company can be reached via phone at (717) 761-2633, via email at investor@riteaid.com, or via fax at 717-975-5871.

This page (NYSE:RAD) was last updated on 6/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial